ES504033A0 - Un peptido - Google Patents

Un peptido

Info

Publication number
ES504033A0
ES504033A0 ES504033A ES504033A ES504033A0 ES 504033 A0 ES504033 A0 ES 504033A0 ES 504033 A ES504033 A ES 504033A ES 504033 A ES504033 A ES 504033A ES 504033 A0 ES504033 A0 ES 504033A0
Authority
ES
Spain
Prior art keywords
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES504033A
Other languages
English (en)
Other versions
ES8305419A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Clinic and Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27389709&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES504033(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scripps Clinic and Research Foundation filed Critical Scripps Clinic and Research Foundation
Publication of ES504033A0 publication Critical patent/ES504033A0/es
Publication of ES8305419A1 publication Critical patent/ES8305419A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES504033A 1980-07-17 1981-07-16 Un peptido Expired ES8305419A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16975880A 1980-07-17 1980-07-17
US20243180A 1980-10-30 1980-10-30
US24805981A 1981-03-27 1981-03-27

Publications (2)

Publication Number Publication Date
ES504033A0 true ES504033A0 (es) 1983-04-01
ES8305419A1 ES8305419A1 (es) 1983-04-01

Family

ID=27389709

Family Applications (1)

Application Number Title Priority Date Filing Date
ES504033A Expired ES8305419A1 (es) 1980-07-17 1981-07-16 Un peptido

Country Status (15)

Country Link
EP (1) EP0044710B2 (es)
KR (1) KR870000702B1 (es)
AU (1) AU559234B2 (es)
CA (1) CA1194794A (es)
DE (1) DE3174241D1 (es)
DK (1) DK318481A (es)
ES (1) ES8305419A1 (es)
FI (1) FI83662C (es)
GR (1) GR74319B (es)
IE (1) IE51410B1 (es)
IL (1) IL63224A (es)
NO (1) NO812341L (es)
NZ (1) NZ197734A (es)
PH (5) PH20629A (es)
PT (1) PT73346B (es)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554101A (en) * 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US5019383A (en) * 1981-01-09 1991-05-28 New York Blood Center, Inc. Fatty acid carriers for synthetic peptides
DE3109696A1 (de) * 1981-03-13 1982-09-30 Gerhard Dr. med. 7800 Freiburg Hunsmann Verfahren zur herstellung eines als impfstoff geeigneten synthetischen peptids und es enthaltender impfstoff
DE3112338C2 (de) * 1981-03-28 1995-02-23 Klaus Von Der Helm Verwendung von Hybridisierungssonden zum Nachweis von HAV
EP0082789B1 (en) * 1981-12-22 1987-04-08 Baylor College of Medicine Immunological composition and method for hepatitis b virus
ZA831547B (en) * 1982-03-15 1984-10-31 New York Blood Center Inc Fatty acid carriers for synthetic vaccines
ZA831854B (en) * 1982-03-26 1984-01-25 Biogen Nv Small peptides with the specificity of foot and mouth disease viral antigens
EP0105346B1 (en) * 1982-04-14 1991-11-13 BITTLE, James L. Synthetic picornavirus antigen
DE3228501A1 (de) * 1982-07-30 1984-02-02 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines herpes-antigens, dazu geeignetes mittel sowie verfahren zu seiner herstellung und die verwendung dieses antigens
ZA836080B (en) * 1982-08-23 1984-04-25 Scripps Clinic Res Broad spectrum influenza antisera
EP0105481A1 (en) * 1982-09-30 1984-04-18 The Wellcome Foundation Limited Novel antigens and vaccines containing them
US4483793A (en) * 1982-10-04 1984-11-20 The Regents Of The University Of California Dimeric oligopeptides as heptenic epitopic sites for hepatitis
JPS59501866A (ja) * 1982-10-11 1984-11-08 ナショナル・リサ−チ・ディベロップメント・コ−ポレイション 腸内ウイルスに対するワクチン接種に有用なポリペプチド
NZ207394A (en) * 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US5242798A (en) * 1983-07-21 1993-09-07 Scripps Clinic And Research Foundation Synthetic polypeptides corresponding to portions of proteinoids translated from brain-specific mRNAs, receptors, methods and diagnostics using the same
US5030565A (en) * 1983-08-17 1991-07-09 Scripps Clinic And Research Foundation Polypeptide-induced monoclonal receptors to protein ligands
EP0162054B1 (en) * 1983-09-30 1991-03-06 Massachusetts Institute Of Technology Production of cdna representing hepatitis a viral sequences
US4615973A (en) * 1983-09-30 1986-10-07 The Rockefeller University Genetically engineered organisms expressing surface proteins of T. cruzi
US4777240A (en) * 1984-03-08 1988-10-11 Scripps Clinic And Research Foundation SV40 expression vector containing HBxAg as an expression marker
US4599231A (en) * 1984-03-09 1986-07-08 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
WO1985004103A1 (en) * 1984-03-09 1985-09-26 Scripps Clinic And Research Foundation Synthetic hepatitis b virus vaccine including both t cell anc b cell determinants
US4599230A (en) * 1984-03-09 1986-07-08 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
US4636463A (en) * 1984-04-05 1987-01-13 Scripps Clinic And Research Foundation Antibodies to human interleukin-2 induced by synthetic polypeptides
US4794168A (en) * 1984-04-24 1988-12-27 Scripps Clinic And Research Foundation Leukemia-associated virus immunogen, vaccine and assay
US4663436A (en) * 1984-04-24 1987-05-05 Scripps Clinic And Research Foundation Leukemia-associated virus immunogen, vaccine and assay
GB8432401D0 (en) * 1984-12-21 1985-02-06 Bennett C E Liver fluke antigens
GB8508685D0 (en) * 1985-04-03 1985-05-09 Minor P D Peptides
JP2702911B2 (ja) * 1985-09-11 1998-01-26 ユナイテツド・バイオメデイカル・インコ−ポレ−テツド 合成ペプチド、並びにそれを用いたエイズおよびプリ・エイズの検出方法
US4735896A (en) * 1986-03-04 1988-04-05 United Biomedical, Inc. Synthetic peptide and process of using same for the detection and diagnosis of AIDS and pre-AIDS conditions
US4772685A (en) * 1985-10-02 1988-09-20 Merck & Co., Inc. Immunogenic peptides of human interleukin-1 and the corresponding anti-peptide antibodies
US4795740A (en) * 1986-05-20 1989-01-03 Cohen Eric A Antiviral peptides and means for treating herpes infections
US5066783A (en) * 1986-05-20 1991-11-19 Cohen Eric A Antiviral peptides and means for treating herpes infections
US4777239A (en) * 1986-07-10 1988-10-11 The Board Of Trustees Of The Leland Stanford Junior University Diagnostic peptides of human papilloma virus
DK354487A (da) * 1986-07-11 1988-01-12 Noboru Yanaihara Oncogen-relaterede peptider
ATE207535T1 (de) * 1987-06-22 2001-11-15 Medeva Holdings Bv Hepatitis-b-oberflächenantigen enthaltendes peptid
AU630591B2 (en) * 1987-07-06 1992-11-05 Peptide Technology Limited Growth hormone related peptide
US5128319A (en) * 1987-08-28 1992-07-07 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
US5055396A (en) * 1987-11-03 1991-10-08 Scripps Clinic And Research Foundation Diagnostic methods and systems for quantifying apo ai
JPH02504395A (ja) * 1988-03-29 1990-12-13 スクリップス　クリニック　アンド　リサーチ　ファウンデーション アポａｉ定量のための診断方法及び診断システム
DE3911794A1 (de) * 1989-04-11 1990-10-18 Thomae Gmbh Dr K Monoklonale antikoerper gegen rekombinaten humanen gewebeplasminogenaktivator mit definierter epitopspezifitaet, deren herstellung und deren verwendung
JPH04503815A (ja) * 1989-07-14 1992-07-09 シェリング・コーポレーション カルボキシル末端から誘導されたｇｍ―ｃｓｆのアンタゴニスト
EP0491077A1 (en) * 1990-12-19 1992-06-24 Medeva Holdings B.V. A composition used as a therapeutic agent against chronic viral hepatic diseases
US7252829B1 (en) 1998-06-17 2007-08-07 Idm Pharma, Inc. HLA binding peptides and their uses
US7611713B2 (en) 1993-03-05 2009-11-03 Pharmexa Inc. Inducing cellular immune responses to hepatitis B virus using peptide compositions
US9340577B2 (en) 1992-08-07 2016-05-17 Epimmune Inc. HLA binding motifs and peptides and their uses
US5387504A (en) * 1992-09-30 1995-02-07 Merck & Co., Inc. Monospecific antibodies and assay system for detecting stromelysin cleavage products
WO1994008597A1 (en) * 1992-10-14 1994-04-28 The Scripps Research Institute Methods for the detection of antigen-specific immune complexes
ES2065254B1 (es) * 1993-01-23 1995-07-16 Inmunologia & Genetica Aplic Peptidos y vacunas sinteticas contra parvovirus canino y otros virus relacionados.
US6632613B1 (en) * 1993-06-02 2003-10-14 University Of Utah Research Foundation Compositions and kits for fluorescence polarization assay of large molecules
ATE256702T1 (de) * 1993-12-09 2004-01-15 Univ Utah Res Found Zusammensetzungen und kits zur fluoreszenzpolarisierungsdosierung von grossen molekülen
JP2001508054A (ja) * 1996-12-30 2001-06-19 イノジェネティックス・ナムローゼ・フェンノートシャップ ＨＢｓＡｇ由来アネキシンＶ結合ポリペプチドおよびその使用
AU1661201A (en) 1999-11-18 2001-05-30 Epimmune, Inc. Heteroclitic analogs and related methods
US7026443B1 (en) 1999-12-10 2006-04-11 Epimmune Inc. Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions
US7462354B2 (en) 1999-12-28 2008-12-09 Pharmexa Inc. Method and system for optimizing minigenes and peptides encoded thereby
EP2339020B1 (en) 2000-10-20 2017-03-08 Como Biotech APS Diagnostic methods based on Pregnancy-associated plasma protein-A (PAAP-A)
US7244580B2 (en) * 2001-11-08 2007-07-17 The Regents Of The University Of California Epsilon immunoglobulin chain derived peptides for induction of anti-IgE antibodies
SI3031910T1 (en) 2002-02-21 2018-05-31 Institute Of Virology Slovak Academy Of Sciences MN / CA IX-SPECIFIC MONOCLONIC PROTECTOR GENERATED FROM MN / CA- DEFROSTABLE MICE AND METHOD OF APPLICATION
WO2008075788A1 (ja) * 2006-12-20 2008-06-26 Shino-Test Corporation ヒトｈｍｇｂ１と特異的に結合する鳥類由来の抗体、ヒトｈｍｇｂ１の免疫学的測定方法及びヒトｈｍｇｂ１の免疫学的測定試薬
US9969794B2 (en) 2012-05-10 2018-05-15 Visterra, Inc. HA binding agents
WO2017083627A1 (en) 2015-11-13 2017-05-18 Visterra, Inc. Compositions and methods for treating and preventing influenza
EP3946613A1 (en) 2019-03-25 2022-02-09 Visterra, Inc. Compositions and methods for treating and preventing influenza

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237224A (en) * 1974-11-04 1980-12-02 Board Of Trustees Of The Leland Stanford Jr. University Process for producing biologically functional molecular chimeras
US4075194A (en) * 1976-12-09 1978-02-21 Yeda Research And Development Co., Ltd. Novel synthetic undecapeptide and clinical assay
AT373280B (de) * 1977-11-08 1984-01-10 Genentech Inc Verfahren zur erzeugung eines spezifischen polypeptids aus einem mikrobiellen rekombinations -clonbildungstraeger
US4193915A (en) * 1978-04-13 1980-03-18 Mckerns Kenneth W Contraceptive, antibody generating, polypeptides
ES487106A0 (es) * 1978-12-22 1981-05-16 Biogen Nv Un metodo para producir al menos un polipeptido que muestra antigenicidad de hbv
US4220565A (en) * 1979-01-18 1980-09-02 Scripps Clinic & Research Foundation Immunochemical conjugates: method and composition
SE447263B (sv) * 1979-04-20 1986-11-03 Bonnierfoeretagen Ab Syntetisk, antigeniskt aktiv polypeptid och antigeniskt medel innehallande nemnda polypeptid
IE52036B1 (en) * 1979-05-24 1987-05-27 Univ California Non-passageable viruses

Also Published As

Publication number Publication date
EP0044710A1 (en) 1982-01-27
PH20133A (en) 1986-10-02
FI812092L (fi) 1982-01-18
EP0044710B1 (en) 1986-04-02
FI83662B (fi) 1991-04-30
NO812341L (no) 1982-01-18
IL63224A0 (en) 1981-10-30
PT73346B (en) 1982-09-02
DE3174241D1 (en) 1986-05-07
KR870000702B1 (ko) 1987-04-07
KR830006423A (ko) 1983-09-24
PH20597A (en) 1987-02-24
FI83662C (fi) 1991-08-12
PT73346A (en) 1981-08-01
AU7283681A (en) 1982-01-21
PH20598A (en) 1987-02-24
IE811595L (en) 1982-01-17
CA1194794A (en) 1985-10-08
DK318481A (da) 1982-01-18
EP0044710B2 (en) 1991-02-06
GR74319B (es) 1984-06-22
IL63224A (en) 1985-05-31
PH20603A (en) 1987-02-24
ES8305419A1 (es) 1983-04-01
NZ197734A (en) 1985-05-31
AU559234B2 (en) 1987-03-05
PH20629A (en) 1987-03-06
IE51410B1 (en) 1986-12-24

Similar Documents

Publication Publication Date Title
ES504033A0 (es) Un peptido
AR231395A1 (es) Un dentifrico
ES505626A0 (es) Un tamiz
DK148075C (da) Sprinklerenhed
ES520997A0 (es) Un metodo para producir un peptido.
ES529683A0 (es) Un polipeptido sintetico
ES526325A0 (es) Un estarcido
ES273317Y (es) Un cubo-rompecabezas
IT1164425B (it) Meccanismo a spazzole
ES296344Y (es) Un carrete
ES538177A0 (es) Un depurador
ES533668A0 (es) Un compuesto fenoxi
ES501878A0 (es) Un procedimiento para preparar un peptido
FR2531843B1 (fr) Bagage a main
ES538804A0 (es) Un compuesto
IT1157070B (it) Interruttore a bilico
ES288368Y (es) Un quitasol
SE8007919L (sv) Pulverspruta
ES522679A0 (es) Un compuesto
ES287714Y (es) Un velocipedo
MX159080A (es) Mejoras a pistola
ES498948A0 (es) Un procedimiento para la obtencion de un peptido.
ES525065A0 (es) Un vector reversible
ES279839Y (es) Un calendario
ES257705Y (es) Un ladrillo

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960401